We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




First of Its Kind Technology Detects Glucose in Human Saliva

By LabMedica International staff writers
Posted on 30 Nov 2023
Print article
Image: Saliva could one day replace blood to monitor people’s health (Photo courtesy of 123RF)
Image: Saliva could one day replace blood to monitor people’s health (Photo courtesy of 123RF)

Blood tests are vital for assessing health, but they often involve uncomfortable procedures, including frequent finger pricks or blood draws by a phlebotomist. Saliva, which shares many biomarkers with blood, has been considered as an alternative for monitoring health indicators like glucose levels. Traditional analysis of saliva for small molecules often requires lab equipment. Now, a new device capable of detecting glucose and adenosine monophosphate (AMP) in saliva with high sensitivity could simplify home health monitoring and eliminate the discomfort of traditional methods.

At the Université de Sherbrooke in Québec, Canada, researchers have adapted electrochemical aptamer-based (E-AB) biosensors, previously used for testing blood samples, to work with saliva. These biosensors generate an electrochemical signal when a custom-designed DNA or RNA aptamer binds to a specific target molecule. Focusing on glucose and AMP—a biomarker linked to gum disease—the team modified existing DNA aptamers to enhance their sensitivity and mounted them on gold electrodes to create the E-AB biosensors. Saliva samples were gathered from participants and combined for testing. The innovative aspect of this approach lies in its simplicity: the biosensors can be directly immersed in saliva without any additional preparation or reagents, making it feasible for at-home patient use.

The researchers observed that their devices could deliver results in just 30 seconds, remained effective in pure saliva for up to three days, and maintained their sensitivity for a week with proper washing after each use. The glucose sensor demonstrated high specificity for its target, and both AMP and glucose sensors could detect these biomarkers at concentrations lower than those usually present in saliva. This breakthrough, particularly in glucose detection in human saliva, holds promise for making health monitoring less invasive and more manageable for individuals with chronic conditions like diabetes.

Related Links:
Université de Sherbrooke

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.